Gilead ups its donation of the Covid-19 drug remdesivir for U.S. hospitals

Gilead ups its donation of the Covid-19 drug remdesivir for U.S. hospitals

Source: 
Stat
snippet: 

Gilead Sciences, the drug company behind the experimental Covid-19 therapy remdesivir, has upped the number of doses it’s donating to the federal government from 607,000 to around 940,000, STAT has learned.